On July 8, 2021 Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, reported that it has been invited to present at the Access to Giving Virtual Investor Conference, which is being held virtually on July 13th – 15th, 2021 (Press release, Nuvo Pharmaceuticals, JUL 8, 2021, View Source [SID1234584701]). Jesse Ledger, Miravo’s President & Chief Executive Officer and Mary-Jane Burkett, Miravo’s Vice President & Chief Financial Officer will be presenting at the conference.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Access to Giving is a conference themed around investor education and advocacy with 50+ companies presenting, a keynote, three distinctive panels and management will be available for 1×1 meetings.

DATE: Thursday, July 15, 2021

TIME: 9:30 a.m. ET

LIVE PRESENTATION /
REPLAY LINK: View Source

To receive additional information, request an invitation or to schedule a 1×1 meeting, please email [email protected]. Investors can register here.

About Access to Giving

Access to Giving is the first-of-its-kind virtual investor conference and will be held July 13th – 15th, 2021. Companies will have the opportunity to tell their story and conduct 1×1 meetings with qualified investors for charity. 100% of monies raised through donations for 1×1 meetings will be given to causes that are focused on financial literacy and financial education.